検索結果 - Anne‐Marie C. Dingemans
-
1
-
2
-
3
-
4
-
5
-
6
-
7
New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management 著者: Jules L. Derks, Noémie Leblay, Sylvie Lantuéjoul, Anne‐Marie C. Dingemans, Ernst‐Jan M. Speel, Lynnette Fernández-Cuesta
出版事項 2018Revisão -
8
Effect of Bisphosphonates, Denosumab, and Radioisotopes on Bone Pain and Quality of Life in Patients with Non–Small Cell Lung Cancer and Bone Metastases: A Systematic Review 著者: Lizza Hendriks, B.C.M. Hermans, M.H.J. van den Beuken-van Everdingen, Monique Hochstenbag, Anne‐Marie C. Dingemans
出版事項 2015Revisão -
9
[18F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients 著者: Steven Petit, Wouter J. C. van Elmpt, Cary Oberije, Erik Vegt, Anne‐Marie C. Dingemans, Philippe Lambin, André Dekker, Dirk De Ruysscher
出版事項 2010Artigo -
10
-
11
-
12
-
13
Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study 著者: Lizza Hendriks, Jules L. Derks, Pieter E. Postmus, Ronald Damhuis, Ruud Houben, Esther G.C. Troost, M. Hochstenbag, Egbert F. Smit, Anne‐Marie C. Dingemans
出版事項 2015Artigo -
14
Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment? 著者: Joline S.W. Lind, Martijn R. Meijerink, Anne‐Marie C. Dingemans, Cornelis van Kuijk, Michel Öllers, Dirk De Ruysscher, Pieter E. Postmus, Egbert F. Smit
出版事項 2010Artigo -
15
Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450) 著者: Dirk De Ruysscher, Rinus Wanders, Lizza Hendriks, Angela van Baardwijk, Bart Reymen, Ruud Houben, Gerben Bootsma, Cordula Pitz, Linda van Eijsden, Anne‐Marie C. Dingemans
出版事項 2018Artigo -
16
Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia 著者: Celine M. Op den Kamp, Ramon Langen, Frank J. M. Snepvangers, Chiel C. de Theije, Johanna M Schellekens, Fabian Laugs, Anne‐Marie C. Dingemans, Annemie Schols
出版事項 2013Artigo -
17
Mature Results of an Individualized Radiation Dose Prescription Study Based on Normal Tissue Constraints in Stages I to III Non–Small-Cell Lung Cancer 著者: Angela van Baardwijk, S. Wanders, Liesbeth Boersma, Jacques Borger, Michel Öllers, Anne‐Marie C. Dingemans, Gerben Bootsma, Wiel Geraedts, Cordula Pitz, Ragnar Lunde, Philippe Lambin, Dirk De Ruysscher
出版事項 2010Artigo -
18
Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens? 著者: Jules L. Derks, Anne‐Marie C. Dingemans, Robert‐Jan van Suylen, Michael A. den Bakker, Ronald Damhuis, Esther C. van den Broek, Ernst‐Jan Speel, Erik Thunnissen
出版事項 2018Artigo -
19
Handgrip weakness, low fat‐free mass, and overall survival in non‐small cell lung cancer treated with curative‐intent radiotherapy 著者: Chris Burtin, Jacques Bezuidenhout, Karin J.C. Sanders, Anne‐Marie C. Dingemans, Annemie M.W.J. Schols, Stéphanie Peeters, Martijn A. Spruit, Dirk K.M. De Ruysscher
出版事項 2020Artigo -
20
Pre-cachexia in patients with stages I–III non-small cell lung cancer: Systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome sy... 著者: Celine M. Op den Kamp, Ramon Langen, Ronnie Minnaard, Marco Kelders, Frank J. M. Snepvangers, M. K.C. Hesselink, Anne‐Marie C. Dingemans, Annemie M.W.J. Schols
出版事項 2011Artigo
関連主題
Medicine
Internal medicine
Lung cancer
Oncology
Cancer
Biology
Chemotherapy
Radiation therapy
Paleontology
Pathology
Stage (stratigraphy)
Radiology
Confidence interval
Surgery
Clinical trial
Cancer research
Adenocarcinoma
Cohort
Disease
Gastroenterology
Gene
Immunotherapy
Malignant pleural effusion
Nuclear medicine
Clinical endpoint
Crizotinib
Epidermal growth factor receptor
Hazard ratio
Immunology
Intensive care medicine